Your daily dose of the clinical news you may have missed.

Hypertension that is resistant or refractory to treatment increases the risk of comorbidity and cardiovascular risk. Click through this at-a-glance review of key issues.

EASD 2024: Amycretin was also found to be safe and well tolerated in adults with obesity and without diabetes.

AI is welcomed by US adults for streamlining the administrative complexity of getting medical care but not so much for replacing health care professionals themselves.

Your daily dose of the clinical news you may have missed.

FDA heightened label warnings about hepatic injury and increased the required frequency of liver function testing after initiation of fezolinetant.

New data shows that favorable CV health in the first trimester is associated with a 35% to 62% lower risk of HDP regardless of level of genetic risk.

Those least likely to schedule further screening mammograms had received a false-positive with recommendation for follow-up after only a short interval.

Presented at ESMO, the findings reflect “a highly discriminate blood-based panel of methylated DNA markers” as well as a robust new marker class for identifying patients with precancerous lesions.

Your daily dose of the clinical news you may have missed.